RAD51C and cancer: Detection ratio of BRCA1, BRCA2, PALB2, ATM, CHEK2, MUTYH, MSH6, RAD51C, BARD1, CDH1, POLE and ERCC3 P/LP variants in the study groups and gnomAD non-cancer population.